Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
—
Company details
Market cap
$4.4B
Revenue
$1.4B
Rev. growth
+11%
Adj. EPS
$4.20
P/E (adj)
19×
Div yield
None
Gross margin
~68%
Segments
2
In plain English
LivaNova is a mid-cap medical-device maker born from the 2015 merger of America's Cyberonics and Italy's Sorin. It plays in two niches where it holds a top-two share: the oxygenators and heart-lung machines that keep patients alive during open-heart surgery (Cardiopulmonary, ~57% of sales), and the implanted vagus-nerve stimulators that treat drug-resistant epilepsy and depression (Neuromodulation, ~43%). Revenue is ~$1.4B, it pays no dividend, and a large Italian environmental liability (SNIA, ~$390M) hangs over the balance sheet.
In simple terms
What LivaNova PLC really sells
LivaNova is a mid-cap medical-device maker born from the 2015 merger of America's Cyberonics and Italy's Sorin. It plays in two niches where it holds a top-two share: the oxygenators and heart-lung machines that keep patients alive during open-heart surgery (Cardiopulmonary, ~57% of sales), and the implanted vagus-nerve stimulators that treat drug-resistant epilepsy and depression (Neuromodulation, ~43%). Revenue is ~$1.4B, it pays no dividend, and a large Italian environmental liability (SNIA, ~$390M) hangs over the balance sheet.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.